Format Changed To Virtual : July 22 - 23
Based on a recent survey of members asking who would be attending in July and based on registrations so far, we’ve made the decision to move ASAP Midyear to a virtual conference on July 22 and 23.

On The Agenda

Thursday, July 22

All times are ET

9:00 - 9:30 The Essential Role of Pharmacists in Securing the Promise of Precision Medicine

Brian Litten, J.D., Chief Strategic Growth Officer, Tabula Rasa HealthCare

The path from personalized to precision medicine has been fraught with debate around the role of the pharmacist, the relevance and actionability of reported pharmacogenomics (PGx) laboratory results, and the reimbursement for lab testing and supporting clinical services. For precision medicine to advance and succeed, all these issues must be addressed simultaneously. After over 20 years of attempts to navigate around these issues, disparate perspectives are now converging and signaling that the widespread adoption of precision medicine and the reimbursement of pharmacists who support these endeavors is upon us. In this session, Brian will focus on the current state of precision medicine, novel technologies being used by pharmacists to amplify the value of precision medicine, and some of the current and future related opportunities for pharmacists to provide reimbursed clinical services to enhance patient safety and care.

9:35 - 10:05 ASAP PDMP Standards and All Prescription Reporting

Kevin Borcher, Pharm.D., Sr. Director, Pharmacy Services and PDMP Director, CyncHealth

In 2018 Nebraska became the first state to leverage the capabilities of the PDMP to report all prescriptions using the ASAP PDMP standard format. Through collaborative efforts, Kevin will update attendees on the benefits and successes gained from this innovative model and what other states are doing.

10:05 - 10:20 Break

10:20 - 11:05 Practical Lessons from The COVID-19 Vaccine Rollout

Brent Fox, Pharm.D., Ph.D., Associate Professor, Auburn University Harrison School of Pharmacy

Over the last 16 months, we have all lived a shared experience that will have a lasting impact on virtually every human being. The effort to develop vaccines for SARS-CoV2 involved specific companies and research centers in a small number of countries. However, rollout of the vaccine in the US required a coordinated effort that included manufacturers, distributors, federal and state governments and agencies, health care institutions, and health care professionals. Accounts of the vaccination experience from everyday Americans highlight differences in communication, efficiency, and follow-up, often with little explanation for the variation. Similarly, accounts from pharmacists suggest challenges related to vaccine acquisition, communication, documentation, and follow-up. As states and regions of the US turn their attention toward a return to normalcy, what lessons has the pharmacy community learned? This session will highlight practical lessons learned from the US rollout of the COVID-19 vaccine.

11:05 - 11:35 340B Market Dynamics: Role of Systems and Strategic Tactics

Ann Johnson, Pharm.D., President, Pharmacy Healthcare Solutions, LLC

Ann will review the basics of the 340B drug program and the role of third-party administrators (TPAs) and accumulator software in managing 340B Program requirements for covered entities and contract pharmacies. We will also review the changing market dynamics and conflicting industry perspectives; recently, several manufacturers have refused to sell products to contract pharmacies at a 340B discount, while the Department of Health and Human Services (HHS) required that this discounted pricing be offered. A timeline of these events will be presented.

11:40 - 12:10 The Future Of Pharmacy Through My Rear View Mirror

Tom Menighan, M.B.A., Sc.D., FAPhA, Partner, Pharmacy Advisors

It’s easy to predict the future. It’s hard to predict “when.” The “when” is often up to the audience attending ASAP. In this session, Tom will look forward to opportunities for pharmacy management systems to facilitate important trends in health care. We WILL see these changes occur. The question is “Who will be the successful change agents?” We will discuss how systems can create value for pharmacists both internally and by expanding integration of multiple platforms and data sets?

Friday, July 23

All times are ET

9:00 - 9:30 Project PAUSE: Management of Psychoactive Medications in Older Adults

Chad Worz, Pharm.D., BCGP, Executive Director & Chief Executive Officer, American Society of Consultant Pharmacists

The use of psychoactive medications has been an area of focus of the Centers for Medicare and Medicaid Services (CMS) in long term care settings for many years. Increasingly, that focus has been limited to measuring utilization as a function of potential inappropriate use. Disadvantages have been created involving star ratings and reimbursement that are consistent with the measures but not with the level of care or appropriate use of medications in these psychoactive medication classes. As CMS looks into assisted living and into the community at the utilization patterns of these medications, a coalition of provider and advocacy groups has proposed a solution that uses current measurement infrastructures to better inform CMS and other stakeholders to true appropriateness of use.

9:35 - 10:05 FDA's New Digital Center of Excellence

Marsha Millonig, M.B.A., B.Pharm., President & CEO, Catalyst Enterprises, LLC

The Food and Drug Administration (FDA) created a new Digital Center of Excellence in late 2020. The Center’s goal is to “empower stakeholders to advance health care by fostering responsible and high-quality digital health innovation.” Digital health includes “categories such as mobile health (mHealth), health information technology (IT), wearable devices, telehealth and telemedicine, and personalized medicine.” The new Digital Health Center will serve as the hub for a variety of initiatives the FDA has already undertaken to help smooth the pathway for digital health approvals and it should help stakeholders by bringing information together in a central location. In this fast-paced session, Marsha will outline the Center’s objectives, its implementation plans, how to access its resources, examples of the type of innovations that the Center will be addressing, and challenge you to think about how digital health may impact your systems.

10:00 - 10:20 Break

10:20 - 10:50 Post-COVID Opportunities: Healthcare Technology and The Delivery of Enhanced Pharmacy Services

Paige Clark, R.Ph., VP of Pharmacy Programs and Policy, Prescryptive Health

The pandemic has provided pharmacies with the opportunity to showcase their value to local communities in the delivery of tests and vaccines. Now pharmacies must act quickly to make their case to state regulators in regard to allowing pharmacies to continue to deliver such services, and other similar services, post-pandemic. Learn how a healthcare technology platform can help pharmacists achieve the goal.

10:50 - 11:20 Value-Based Contracting: Essential Infrastructure for Community Pharmacies

Troy Trygstad, Pharm.D., M.B.A., Ph.D., Executive Director, CPESN USA

Value-based arrangements are finally coming to community pharmacy. In this presentation, Troy will discuss how the infrastructure needed to support value-based contracting differs for pharmacy and medical providers, as well as where it’s similar. He will further outline how we can continue charting a course for maximal pharmacy value expression.


“As always, I enjoy the intimate nature of ASAP conferences. The content is always relevant and the networking opportunity is greatly appreciated.”

“ASAP continues to be the best conference to discuss business opportunities between vendors. Other shows require vendors to focus on customers, which prevents meaningful discussions.”

“Love the concise overview of many relevant topics by great speakers.” “The most valuable conference I’ve attended because the topics were great.”

Or watch these sample videos of presentation streams from the 2021 Annual Conference

Who Attends ASAP Conferences?

Companies and Organizations

ACAG Consulting
Advanced Pharmacy
AIDS Healthcare Foundation
Alliance of States with Prescription Monitoring Programs
American Immunization Registry Association
American Pharmacists Association
American Pharmacy Alliance
American Society of Consultant Pharmacists
APhA Foundation
Appriss, Inc.
Auburn University Harrison School of Pharmacy
Avery Weigh-Tronix
BestRx Pharmacy Software
Carolinas HealthCare System
Catalyst Enterprises
Change Healthcare
Community Care of North Carolina
Costco Wholesale
Digital Pharmacist
Elsevier/Gold Standard
eRx Network
Fairleigh Dickinson University School of Pharmacy
First DataBank
Health Business Systems
Health Market Science
Infoworks Data Services
Integra LTC Solutions
J M Smith Corporation
KeyCentrix, Inc.
Klingensmith's Drug Stores
LexisNexis Risk Solutions
Liberty Software
National Alliance for Model State Drug Laws
National Association of Boards of Pharmacy
PANTHERx Specialty Pharmacy
PDR by ConnectiveRx
Managed Health Care Associates
Mayo Clinic Pharmacy
McKesson Pharmacy Systems
Mediware Information Systems/CPR+
MedQuest Pharmacy
Minnesota Board of Pharmacy, PDMP
National Community Pharmacists Association
Pharmaceutical Technololgies
Pharmacy Data Network
Pharmacy Healthcare Solutions Inc.
Pharmacy Providers of Oklahoma
Pharmacy Quality Alliance, Inc,
Pharmacy Quality Solutions
Pharmacy Technology Consulting
PharmBlue and RX Blue Star Solutions
PillGuard Medication Delivery Systems
Pocket Nurse
Retail Insights
Rexam Prescription Products
Rice’s Pharmacy
Rite Aid Corporation
Rx|X Consulting
Rx30 Pharmacy System
RxMaster Pharmacy Systems
Speed Script
Tabula Rasa HealthCare
Target Corp.
Tri State Distribution
U.S. Pharmacopeial Convention (USP)
United Drugs
Valu-Med Pharmacy
VUCA Health
Wolters Kluwer Health


Account Executive
Account Manager
Applications Director
Associate Director, Education
Business Consultant
Chief Strategy Officer
Chief Technology Innovation Officer
Director and Product Manager
Director of Clinical Services
Director of Pharmacy
Director, Account Management
Director, Business Development
Director, Channel Partner Sales
Director, Drug Product Data
Director, Finance
Director, Government Affairs
Director, National Accounts, Pharmacy
Director, Pharmacy Sales
Director, Pharmacy Systems Solutions
Director, Product Development
Director, Product Management
Director, Sales and Marketing
Director, Supplier Services
Division Rep., Sr.
Division VP, Sales
Executive VP
Executive VP, Sales US
General Manager
Lead Coordinator
Manager, Software Development
Managing Partner
National Director, Pharmacy
National Sales
President and CEO
Product Manager
Regional Director, Pharmacy
Sales Engineer
Sales Executive
Sr. Account Executive
Sr. Director, Business Development
Sr. Director, Data Strategy
Sr. Director, Industry Development
Sr. Director, Management Affairs
Sr. Director, Retail Business Development
Sr. Global Program Manager
Sr. Manager, Chief Pharmacy Officer
Sr. Manager, Market Analysts
Sr. Territory Manager
SVP, Operations
SVP, Retail Network Development
Systems Analytics Research and Development
Technical Account Manager
VP, Corporate Strategy and Business Development
VP, Industry Relations
VP, Information Technology
VP, Marketing
VP, Marketing and Industry Relations
VP, National Pharmacy Alliances
VP, Pharmacy Services
VP, Product and Client Services
VP, Product Management
VP, Professional and Regulatory Affairs
VP, Systems and Development
Worldwide Sr. Marketing Manager